SCHEMBL7876455

SCHEMBL7876455

COC(=O)c1ccc(NC(=O)/C=C/c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.54
RARB P10826 3/20 0.54
RARG P13631 3/20 0.54
CYP3A4 P08684 7/20 0.53
MEN1 O00255 7/20 0.53
KMT2A Q03164 7/20 0.53
MAPT P10636 7/20 0.53
ALDH1A1 P00352 6/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
KDM4E B2RXH2 4/20 0.53
CYP2C19 P33261 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
HPGD P15428 1/20 0.53
CYP26A1 O43174 5/20 0.50
MMP1 P03956 3/20 0.50
MMP2 P08253 3/20 0.50
MMP9 P14780 3/20 0.50
MAPK1 P28482 4/20 0.49
TSHR P16473 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876451 1.00 RARA (0.54) RARARARBRARGCYP3A4MEN1
SCHEMBL7879849 0.88 RARB (0.70) RARARARBRARGCYP3A4MEN1
SCHEMBL7879855 0.88 RARB (0.70) RARARARBRARGCYP3A4MEN1
SCHEMBL1615329 0.85 RARB (0.72) RARARARBRARGCYP3A4MAPT
SCHEMBL1615774 0.85 RARB (0.72) RARARARBRARGCYP3A4MAPT
SCHEMBL1615332 0.85 RARB (0.72) RARARARBRARGCYP3A4MAPT
SCHEMBL9187417 0.81 CYP26A1 (0.60) RARARARBRARGCYP3A4MEN1
SCHEMBL9187421 0.81 CYP26A1 (0.60) RARARARBRARGCYP3A4MEN1
SCHEMBL14425237 0.81 MAPT (0.48) RARARARBRARGCYP3A4MEN1
SCHEMBL7878413 0.80 ALDH1A1 (0.58) RARARARBRARGCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6326510-B1 SKIN DISORDERS; ANTICANCER AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-12-04 US disclosed